[go: up one dir, main page]

UA86132U - Pharmaceutical formulation for treating endo- and ectoparasitoses - Google Patents

Pharmaceutical formulation for treating endo- and ectoparasitoses

Info

Publication number
UA86132U
UA86132U UAU201309321U UAU201309321U UA86132U UA 86132 U UA86132 U UA 86132U UA U201309321 U UAU201309321 U UA U201309321U UA U201309321 U UAU201309321 U UA U201309321U UA 86132 U UA86132 U UA 86132U
Authority
UA
Ukraine
Prior art keywords
ectoparasitoses
pharmaceutical formulation
treating endo
endo
treating
Prior art date
Application number
UAU201309321U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Юрий Викентьевич Соколов
Original Assignee
Общество С Ограниченной Ответственностью "Ат Биофарм"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Ат Биофарм" filed Critical Общество С Ограниченной Ответственностью "Ат Биофарм"
Priority to UAU201309321U priority Critical patent/UA86132U/en
Publication of UA86132U publication Critical patent/UA86132U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The pharmaceutical formulation for treating endo- and ectoparasitoses contains Avermectin, co-solvent, micelle-generating agent, excipients, distilled water, and steric stabilizer.
UAU201309321U 2013-07-25 2013-07-25 Pharmaceutical formulation for treating endo- and ectoparasitoses UA86132U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201309321U UA86132U (en) 2013-07-25 2013-07-25 Pharmaceutical formulation for treating endo- and ectoparasitoses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201309321U UA86132U (en) 2013-07-25 2013-07-25 Pharmaceutical formulation for treating endo- and ectoparasitoses

Publications (1)

Publication Number Publication Date
UA86132U true UA86132U (en) 2013-12-10

Family

ID=52285703

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201309321U UA86132U (en) 2013-07-25 2013-07-25 Pharmaceutical formulation for treating endo- and ectoparasitoses

Country Status (1)

Country Link
UA (1) UA86132U (en)

Similar Documents

Publication Publication Date Title
IL267997A (en) Compositions, formulations and methods for treating ocular diseases
MX378273B (en) ACTIVE COMPOUNDS TOWARDS BROMODOMAINS.
GB201411465D0 (en) Active pharmaceutical ingredient (api) comprising cannabinoids for use in the treatment of cancer
EP3263135A4 (en) Pharmaceutical composition for treating cancer comprising microrna as active ingredient
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
CL2015001985A1 (en) Thiazolcarboxamides and pyridinecarboxamide compounds, pim kinase inhibitors.
DK2986304T3 (en) PHARMACEUTICAL COMPOSITION, TREATMENT PROCEDURES AND USES.
MX2016015093A (en) Boronic acid derivatives and therapeutic uses thereof.
GB2541571A (en) Pharmaceutical compositions
MX377340B (en) SOLID SOLUTION COMPOSITIONS AND USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES.
HK1220980A1 (en) Methods and compositions for treatment of pompe disease
MX2016012574A (en) Substituted heteroaryl compounds and methods of use.
MX2015010791A (en) Methods of treating cancer and preventing drug resistance.
EP3068442A4 (en) Bionanofluid for use as a contrast, imaging, disinfecting and/or therapeutic agent
MX373129B (en) INDOLIZINE DERIVATIVES AS PHOSPHOINOSITIDE-3 KINASE INHIBITORS.
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
HK1217650A1 (en) Compositions and methods for treating severe pain
CL2015002897A1 (en) Bace1 inhibitors
DK4119569T3 (en) Conjugated antisense compounds for use in therapy
CL2015001202A1 (en) Compounds derived from oxazolidin-2-one-pyrimidine; pharmaceutical composition and combination and use in the treatment of cancer.
PH12017500602A1 (en) Methods for treating ocular conditions
CL2014001959A1 (en) Compounds derived from substituted phenyl-1h-imidazo [1,2-b] pyrazole; preparation procedure; pharmaceutical composition; and use in the treatment of cancer.
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
EP3630113A4 (en) PHARMACEUTICAL COMPOSITION, INCLUDING PDE9 INHIBITOR
EP3110490A4 (en) Multiple chamber, expandable therapeutic agent delivery device